Top Markets
Coin of the day
Verici Dx plc Verici Dx plc

Verici Dx plc

VRCI
Clasificación en acciones #40978
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney... Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular rejection; and Protega, an innovative liquid biopsy aiming to predict the risk of fibrosis and eventual graft failure. Established in 2020, Verici Dx plc maintains its headquarters in Penarth, United Kingdom.
Precio por acción
$0.00338543
Capitalización bursátil
$56.59K
Cambio (1 día)
-0.48%
Cambio (1 año)
-52.51%
País
GB
Comercio Verici Dx plc (VRCI)

Categoría

Ratio P/S de Verici Dx plc (VRCI)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Verici Dx plc, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Verici Dx plc desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
4.61 -
US
5.46 -
US
- -
CN
9.92 -
US
15.33 -
US